Veradermics (MANE) Enterprise Value (2026)

Veradermics (MANE) has 3 years of Enterprise Value data on file, last reported at -$390.8 million in Q1 2026.

• Quarterly Enterprise Value changed N/A year-over-year to -$390.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$390.8 million (changed N/A YoY) and the FY2025 annual result came in at -$141.9 million, down 167.24% from the prior year.
• Enterprise Value slipped to -$390.8 million in Q1 2026, from -$141.9 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$53.1 million in Q4 2024 to a low of -$390.8 million in Q1 2026.
• A 3-year average of -$195.2 million and a median of -$141.9 million in 2025 frame the typical range for Enterprise Value.
• The widest YoY moves for Enterprise Value: up 167.24% in 2025, down 167.24% in 2025.
• Tracing MANE's Enterprise Value over 3 years: stood at -$53.1 million in 2024, then tumbled by 167.24% to -$141.9 million in 2025, then slumped by 175.48% to -$390.8 million in 2026.
• The last three Enterprise Value figures came in at -$390.8 million (Q1 2026), -$141.9 million (Q4 2025), and -$53.1 million (Q4 2024), per Business Quant data.